Medical Equipment

ELEHEAR Earns Two 2026 Hearing Technology Innovator Awards™ from Hearing Health & Technology Matters

Beyond 2 Pro and ElePro® Plus awarded industry recognition as ELEHEAR continues its mission to make personalized hearing care more accessible CHICAGO, Oct. 13, 2026 /PRNewswire/ -- ELEHEAR , a company specializing in AI-powered hearing solutions, has been named a two-time w...

2026-10-13 19:00 1985

The Right Doctor Isn't Always One Doctor

Why complex brain and spine conditions increasingly call for specialists to work across disciplines.   KUALA LUMPUR, Malaysia, Oct. 13, 2026 /PRNewswire/ -- When faced with a brain, spine or neurological condition, one of the first questions a patient or family member may ask is: Which doctor sh...

2026-10-13 16:15 1591

SPARX Global Randomized Controlled Trial by Translumina Initiated to Advance Evidence for Drug-Coated Balloons in Complex Coronary Disease

LUCERNE, Switzerland and NEW DELHI, Oct. 13, 2026 /PRNewswire/ -- The SPARX Global Randomized Controlled Trial (RCT) has been officially initiated, marking the launch of the multinational randomized trial evaluating a drug-coated balloon (DCB)-first strategy against contemporary drug-eluting sten...

2026-10-13 02:11 3181

Fair2Care: Canton Fair Launches International Medical Experience for the First Time

GUANGZHOU, China, Oct. 12, 2026 /PRNewswire/ -- The 140th Canton Fair will open on October 15 with a brand-new experience for attendees. For the first time, the Fair is introducing an exclusive Fair2Care International Medical Experience Program. The program features a dual experience model that c...

2026-10-12 21:01 2621

Lunit and Discovery Life Sciences Collaborate to Expand AI-Powered Tissue Analysis for Biopharma Research

Collaboration expands access to Lunit's AI-powered pathology platform by combining it with Discovery Life Sciences' global biospecimen and specialty laboratory capabilities, enabling standardized tissue insights for biomarker research and drug development. SEOUL, South Korea, Oct. 12, 2026 /PRNe...

2026-10-12 21:00 2373

T-MAXIMUM's B7-H3-Targeted Allogeneic CAR-T MT027 Receives FDA Clearance for Phase 2 Study in Brain Metastases from Lung and Breast Cancer

BEIJING, Oct. 12, 2026 /PRNewswire/ -- T-MAXIMUM PHARMACEUTICAL ("T-MAXIMUM") today announced that the U.S. Food and Drug Administration (FDA) has cleared the company to initiate a Phase 2 clinical study of MT027, its internally developed, B7-H3-targeted universal (allogeneic) CAR-T therapy, for ...

2026-10-12 18:50 1876

CLASSYS Appoints Former Bain & Company Partner Jung-hee Bae as Chief Commercial Officer to Accelerate Global Expansion and Growth

- Appoints Vice President Jung-hee Bae to lead the newly established Go-to-Market (GTM) Center, overseeing domestic and international sales and marketing - AI and data-driven marketing and operations expert to spearhead expansion across the Americas, China and Europe while reinforcing the company...

2026-10-12 14:49 3679

Three Korean Deep-Tech Firms Seek Singapore Partners in October

The pre-screened companies span smart-city positioning, AI cardiac screening and functionalcoatings,withSingaporemeetingsplannedfor26-29October. SINGAPORE, Oct. 12, 2026 /PRNewswire/ -- Three technology companies supported by the Incheon Center for Creative Economy & Innovation (Incheon CCEI) - I...

2026-10-12 10:00 4278

RingConn Receives FDA 510(k) Clearance for Non-Invasive Blood Oxygen (SpO2) Measurement

Shenzhen, China, Oct. 10, 2026 /PRNewswire/ -- Shenzhen Ninenovo Technology Limited, the parent company of RingConn, announced that its Smart Ring has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for non-invasive blood oxygen (SpO2) measurement (Clearance No. K260490...

2026-10-10 15:52 3311

First Patient Dosed in Phase III Perioperative Study of Cadonilimab (PD-1/CTLA-4) in Colon Cancer

HONG KONG, Oct. 10, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in a Phase III clinical study (COMPASSION-40/AK104-313) evaluating cadonilimab, its first-in-class PD-1/CTLA-4 bispecific antibody, as monotherapy in the neoa...

2026-10-10 12:41 3193

Invetech & MeMed win 2026 Good Design Award Gold for MeMed Key™

Award recognizes innovation, design excellence, and impact in Engineering Design SAN DIEGO, Oct. 9, 2026 /PRNewswire/ -- Invetech, a product realization company that designs, engineers and manufactures fully customizable platforms, announced that its work on the MeMed Key™ has been recognized wit...

2026-10-10 04:00 2722

MIDEA COMPLETES THE ACQUISITION OF ESAOTE

Midea Group marks its commitment to healthcare and innovation by completing the acquisition of Esaote   GENOA, Italy, Oct. 9, 2026 /PRNewswire/ -- Esaote S.p.A., a leader in the medical imaging sector, announces the completion of the controlling stake acquisition of its share capital by Midea – ...

2026-10-09 18:00 2602

Wellysis Secures FDA 510(k) Clearance for AI-Powered ECG Analysis Software, S-Patch CardioAI

* Adds FDA-cleared AI analysis to Wellysis' S-Patch ECG monitoring solution, expanding its capabilities beyond ECG acquisition * Enables FDA-cleared AI analysis of S-Patch ECG data to be integrated into third-party ECG platforms and existing clinical workflows * Designed to streamline ECG re...

2026-10-08 22:00 4427

Helfie Signs MOU with Homa Bay Kenya Ministry of Health for TB and Hypertension Screening Pilot

Population-scale pilot will target 100,000 of Homa Bay's most vulnerable people  across five sub-counties. MELBOURNE, Australia, Oct. 8, 2026 /PRNewswire/ -- Helfie AI ("Helfie"), an AI-powered preventive network transforming global healthcare, today announced it has signed a Memorandum of Unders...

2026-10-08 21:00 2978

Sisram Medical Announces Share Repurchase Plan for Up to 1% of Issued Shares

Reinforcing Confidence in Long-Term Growth and Commitment to Shareholder Returns HONG KONG, Oct. 8, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK), a global wellness group offering Energy-Based Devices ("EBD"), injectables, and other complementary solutions, today an...

2026-10-08 18:16 5970

ZEISS acquires Ceres Holographics to accelerate holography industrialization

Combining decades-long holography expertise with complementary holographic innovations JENA, Germany, Oct. 8, 2026 /PRNewswire/ -- ZEISS has announced the acquisition of Ceres Holographics, a pioneering holographic technology company headquartered in Livingston, Scotland. Ceres Holographics beco...

2026-10-08 17:12 1895

Resonant Clinical Solutions and Haier Biomedical Introduce an Innovative Benchtop Centrifuge with a Natural Refrigerant

Exclusive partnership results in a user-centric, hydrocarbon-cooled centrifuge purpose-built for clinical trials – years ahead of upcoming F-gas regulatory changes in Europe and the U.S. LEESBURG, Va. and QINGDAO, China, Oct. 7, 2026 /PRNewswire/ -- Resonant Clinical Solutions – a global clinica...

2026-10-07 20:30 3314

Flat Medical Surpasses 30 U.S. Hospitals and Pain Centers Using the EpiFaith® Smart Syringe in Routine Clinical Practice

Adoption spans obstetric anesthesia and interventional pain management, as major integrated delivery networks begin groundwork for system-wide conversion AUSTIN, Texas, Oct. 7, 2026 /PRNewswire/ -- Flat Medical, a provider of precision needle access and guidance solutions for anesthesia, critical...

2026-10-07 20:08 3251

Cambridge Heartwear Awarded £184 Million NHS Tender for World's First Medical-Grade, Wirelessly Charged, Reusable ECG Wearable

CAMBRIDGE, England, Oct. 7, 2026 /PRNewswire/ -- Cambridge Heartwear® Limited ( www.camheartwear.com

2026-10-07 01:13 4386
12345 ... 147